Back to search
FDAFDA · Food and drugs·Recall number Z-2450-2015

Dimension Vista B®2-Microglobulin Flex Reagent Cartridge (B2MIC); Product Usage: The B2MIC method is an in vitro diagnostic test for the quantitative measurement of B®2-Microglobulin in human serum, heparinized plasma, EDTA plasma and urine on the Dimension Vista System. Measurements of B®2-Microglobulin aid in the diagnosis of active rheumatoid arthritis and kidney disease.

Published September 2, 2015 · Recall initiated: July 23, 2015

Summary

FDA records medical device Class II recall Z-2450-2015, published September 2, 2015 and initiated July 23, 2015. Recalling firm: Siemens Healthcare Diagnostics, Inc.; Status: Terminated; Reported quantity: Total 1655 units; Lot: Lot Number:15037MA; ExpDate: 2016-07-14 Lot # 15175MA; ExpDate: 2015-11-17; Lot # 15204MA; Expdate: 2017-01-13; Lot #15246MA; expdate: 2017-02-26 Lot # 15267MA; expdate: 2017-02-26. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

customers are receiving a high number of Abnormal Assay Errors or are not able to calibrate B2MIC when using Flex reagent cartridge B2MIC various lots. In failure mode, there is the potential for falsely depressed beta2-Microglobulin results on the Dimension Vista system due to assay reagent contamination.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Siemens Healthcare Diagnostics, Inc.
Distributor
US Nationwide Distribution in the states of TN, AZ, CT, Fl, CA, NY and WI
Lot
Lot Number:15037MA; ExpDate: 2016-07-14 Lot # 15175MA; ExpDate: 2015-11-17; Lot # 15204MA; Expdate: 2017-01-13; Lot #15246MA; expdate: 2017-02-26 Lot # 15267MA; expdate: 2017-02-26
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Dimension Vista B®2-Microglobulin Flex Reagent Cartridge (B2MIC); Product Usage: The B2MIC method is an in vitro diagnostic test for the quantitative measurement of B®2-Microglobulin in human serum, heparinized plasma, EDTA plasma and urine on the Dimension Vista System. Measurements of B®2-Microglobulin aid in the diagnosis of active rheumatoid arthritis and kidney disease. recalled?

Yes. FDA published recall Z-2450-2015 on September 2, 2015. Reported hazard: customers are receiving a high number of Abnormal Assay Errors or are not able to calibrate B2MIC when using Flex reagent cartridge B2MIC various lots. In failure mode, there is the potential for falsely depressed beta2-Microglobulin results on the Dimension Vista system due to assay reagent contamination.

What should I do if I have this product?

Voluntary: Firm initiated · Letter